DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
van der Heijde D, Gladman DD, Kishimoto M. et al.
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1).
J Rheumatol. 2017
Access:
We do not assume any responsibility for the contents of the web pages of other providers.